{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:18:29Z","timestamp":1770470309666,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015496","name":"CIBERNED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Generalitat de Catalunya Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.phrs.2021.105745","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T03:25:28Z","timestamp":1624677928000},"page":"105745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Heteromerization between \u03b12A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8532-2954","authenticated-orcid":false,"given":"Ver\u00f2nica","family":"Casad\u00f3-Anguera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-5753","authenticated-orcid":false,"given":"Estefan\u00eda","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"S\u00e1nchez-Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning Sheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-0151","authenticated-orcid":false,"given":"Jordi","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Homar-Ruano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enric I.","family":"Canela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicent","family":"Casad\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2021.105745_bib1","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1007\/s12035-018-1413-1","article-title":"Revisiting the functional role of dopamine D4 receptor gene polymorphisms: heteromerization-dependent gain of function of the D4.7 receptor variant","volume":"56","author":"S\u00e1nchez-Soto","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2021.105745_bib2","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1523\/JNEUROSCI.4525-13.2015","article-title":"Norepinephrine activates dopamine d4 receptors in the rat lateral habenula","volume":"35","author":"Root","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2021.105745_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1124\/mol.115.101808","article-title":"Evidence for noncanonical neurotransmitter activation: norepinephrine as a dopamine D2-like receptor agonist","volume":"89","author":"S\u00e1nchez-Soto","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105745_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001347","article-title":"Circadian-related heteromerization of adrenergic and dopamine D\u2084 receptors modulates melatonin synthesis and release in the pineal gland","volume":"10","author":"Gonzalez","year":"2012","journal-title":"PLOS Biol."},{"key":"10.1016\/j.phrs.2021.105745_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/mp.2011.93","article-title":"Dopamine D4 receptor, but not the ADHD-associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain","volume":"17","author":"Gonzalez","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105745_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601631","article-title":"Key role of the dopamine D4 receptor in the modulation of corticostriatal glutamatergic neurotransmission","volume":"3","author":"Bonaventura","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phrs.2021.105745_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.mce.2009.05.013","article-title":"Thyroid hormone and adrenergic signaling interact to control pineal expression of the dopamine receptor D4 gene (Drd4)","volume":"314","author":"Kim","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.phrs.2021.105745_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1094-1","article-title":"Global daily dynamics of the pineal transcriptome","volume":"344","author":"Bustos","year":"2011","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.phrs.2021.105745_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0306-4522(97)00386-2","article-title":"Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors","volume":"83","author":"Tarazi","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2021.105745_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/(SICI)1098-2396(20000601)36:3<222::AID-SYN6>3.0.CO;2-H","article-title":"Presynaptic dopamine D4 receptor localization in the rat nucleus accumbens shell","volume":"36","author":"Svingos","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.phrs.2021.105745_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbr.2009.11.037","article-title":"Dopamine D4-receptor modulation of cortical neuronal network activity and emotional processing: implications for neuropsychiatric disorders","volume":"208","author":"Lauzon","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2021.105745_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1113\/JP271317","article-title":"Aberrant regulation of synchronous network activity by the attention-deficit\/hyperactivity disorder-associated human dopamine D4 receptor variant D4.7 in the prefrontal cortex","volume":"594","author":"Zhong","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2021.105745_bib13","first-page":"121","article-title":"Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder","volume":"1","author":"LaHoste","year":"1996","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105745_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s004390050166","article-title":"The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus","volume":"98","author":"Chang","year":"1996","journal-title":"Hum. Genet."},{"key":"10.1016\/j.phrs.2021.105745_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1086\/420854","article-title":"The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus","volume":"74","author":"Wang","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.phrs.2021.105745_bib16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of attention-deficit\/hyperactivity disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105745_bib17","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/hmg\/ddl152","article-title":"Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD)","volume":"15","author":"Li","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2021.105745_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00439-009-0694-x","article-title":"Candidate gene studies of ADHD: a meta-analytic review","volume":"126","author":"Gizer","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/j.phrs.2021.105745_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tics.2014.01.010","article-title":"Personality traits and vulnerability or resilience to substance use disorders","volume":"18","author":"Belcher","year":"2014","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.phrs.2021.105745_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41398-020-0755-4","article-title":"DRD4 48 bp multiallelic variants as age-population-specific biomarkers in attention-deficit\/hyperactivity disorder","volume":"10","author":"Bonvicini","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105745_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.b.30557","article-title":"Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: Implications for impulsivity","volume":"147","author":"Congdon","year":"2008","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet."},{"key":"10.1016\/j.phrs.2021.105745_bib22","series-title":"Routledge Handbook of Philosophy and Science of Addiction","first-page":"286","article-title":"Choice impulsivity. A drug-modifiable personality trait","author":"Belcher","year":"2018"},{"key":"10.1016\/j.phrs.2021.105745_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/scan\/nss020","article-title":"Polymorphic variation in the dopamine D4 receptor predicts delay discounting as a function of childhood socioeconomic status: evidence for differential susceptibility","volume":"8","author":"Sweitzer","year":"2013","journal-title":"Soc. Cogn. Affect. Neurosci."},{"key":"10.1016\/j.phrs.2021.105745_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ajmg.b.20018","article-title":"Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit\/hyperactivity disorder?","volume":"120B","author":"Roman","year":"2003","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.phrs.2021.105745_bib25","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.mp.4001605","article-title":"Association and linkage of \u03b1-2A adrenergic receptor gene polymorphisms with childhood ADHD","volume":"10","author":"Park","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105745_bib26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/mp.2013.140","article-title":"Alpha-2A adrenergic receptor gene variants are associated with increased intra-individual variability in response time","volume":"19","author":"Cummins","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2021.105745_bib27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0269881118798612","article-title":"Differential \u03b12A- and \u03b12C-adrenoceptor protein expression in presynaptic and postsynaptic density fractions of postmortem human prefrontal cortex","volume":"33","author":"Erdozain","year":"2019","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2021.105745_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2007.03.015","article-title":"\u03b12A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex","volume":"129","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2021.105745_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1196\/annals.1417.007","article-title":"Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function","author":"Brennan","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.phrs.2021.105745_bib30","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/sj.npp.1301603","article-title":"Stimulation of \u03b12-adrenoceptors suppresses excitatory synaptic transmission in the medial prefrontal cortex of rat","volume":"33","author":"Ji","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2021.105745_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuron.2010.12.001","article-title":"Facilitation of \u03bc-opioid receptor activity by preventing \u03b4-opioid receptor-mediated codegradation","volume":"69","author":"He","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2021.105745_bib32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.phrs.2018.11.032","article-title":"Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model","volume":"139","author":"Casad\u00f3-Anguera","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105745_bib33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pharmthera.2007.05.010","article-title":"Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index","volume":"116","author":"Casad\u00f3","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2021.105745_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.113.008052","article-title":"G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives","volume":"66","author":"Ferr\u00e9","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phrs.2021.105745_bib35","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.bcp.2009.07.012","article-title":"Useful pharmacological parameters for G-protein-coupled receptor homodimers obtained from competition experiments. Agonist-antagonist binding modulation","volume":"78","author":"Casad\u00f3","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105745_bib36","doi-asserted-by":"crossref","first-page":"8438","DOI":"10.1007\/s12035-018-1004-1","article-title":"\u03b12A- and \u03b12C-adrenoceptors as potential targets for dopamine and dopamine receptor ligands","volume":"55","author":"S\u00e1nchez-Soto","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2021.105745_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105159","article-title":"Allosteric modulation of G protein\u2013coupled receptors","volume":"47","author":"May","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2021.105745_bib38","doi-asserted-by":"crossref","first-page":"E3609","DOI":"10.1073\/pnas.1507704112","article-title":"Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer","volume":"112","author":"Bonaventura","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2021.105745_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1042\/BST20150276","article-title":"Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex","volume":"44","author":"Casad\u00f3-Anguera","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phrs.2021.105745_bib40","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nchembio.623","article-title":"CODA-RET reveals functional selectivity as a result of GPCR heteromerization","volume":"7","author":"Urizar","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.phrs.2021.105745_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1124\/mol.114.093096","article-title":"Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer","volume":"86","author":"Guitart","year":"2014","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105745_bib42","series-title":"Progress in Molecular Biology and Translational Science","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/bs.pmbts.2019.11.006","article-title":"Oligomerization of G protein-coupled receptors: still doubted?","author":"Ferr\u00e9","year":"2020"},{"key":"10.1016\/j.phrs.2021.105745_bib43","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1080\/17460441.2019.1664469","article-title":"Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs","volume":"14","author":"Casad\u00f3-Anguera","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.phrs.2021.105745_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pbb.2005.08.001","article-title":"A-412997 is a selective dopamine D4 receptor agonist in rats","volume":"82","author":"Moreland","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.phrs.2021.105745_bib45","doi-asserted-by":"crossref","first-page":"16853","DOI":"10.1523\/JNEUROSCI.1844-13.2013","article-title":"Dopamine D4 receptor excitation of lateral habenula neurons via multiple cellular mechanisms","volume":"33","author":"Good","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2021.105745_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186732","article-title":"Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus","volume":"12","author":"Furth","year":"2017","journal-title":"PLOS One"},{"key":"10.1016\/j.phrs.2021.105745_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0014-2999(99)00715-3","article-title":"Functional assessment of recombinant human \u03b12-adrenoceptor subtypes with cytosensor microphysiometry","volume":"385","author":"Pihlavisto","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105745_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00210-008-0295-6","article-title":"Partial agonism at the human \u03b12A-autoreceptor: role of binding duration","volume":"378","author":"Hoeren","year":"2008","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105745_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/157015906776359586","article-title":"Heterotrimeric G proteins: insights into the neurobiology of mood disorders","volume":"4","author":"Gonzalez-Maeso","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.phrs.2021.105745_bib50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymeth.2008.06.014","article-title":"Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay","volume":"45","author":"S\u00f6derberg","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.phrs.2021.105745_bib51","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s12035-018-1120-y","article-title":"Adenosine A1-dopamine D1 receptor heteromers control the excitability of the spinal motoneuron","volume":"56","author":"Rivera-Oliver","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2021.105745_bib52","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/s41467-018-03522-3","article-title":"Evidence for functional pre-coupled complexes of receptor heteromers and adenylyl cyclase","volume":"9","author":"Navarro","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2021.105745_bib53","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1172\/JCI126912","article-title":"Opioid\u2013galanin receptor heteromers mediate the dopaminergic effects of opioids","volume":"129","author":"Cai","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2021.105745_bib54","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1007\/s12035-019-1564-8","article-title":"Biased G protein-independent signaling of dopamine D1-D3 receptor heteromers in the nucleus accumbens","volume":"56","author":"Guitart","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2021.105745_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12915-020-0739-0","article-title":"Control of glutamate release by complexes of adenosine and cannabinoid receptors","volume":"18","author":"K\u00f6falvi","year":"2020","journal-title":"BMC Biol."},{"key":"10.1016\/j.phrs.2021.105745_bib56","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.tips.2007.06.006","article-title":"\u03b2-Arrestin-biased ligands at seven-transmembrane receptors","volume":"28","author":"Violin","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2021.105745_bib57","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41467-017-02606-w","article-title":"Gs-versus golf-dependent functional selectivity mediated by the dopamine D1 receptor","volume":"9","author":"Yano","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821003297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:33:33Z","timestamp":1760913213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821003297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":57,"alternative-id":["S1043661821003297"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105745","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heteromerization between \u03b12A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105745"}}